Netskope enters the final days of July with its internal contradiction deepening — the short side is expanding aggressively while the Street just turned more constructive, a divergence that points straight at the September 2 earnings date as the resolution.
The short positioning has continued its rapid build. Estimated short interest hit roughly 28.7 million shares on July 23, more than double the ~14 million recorded in mid-June. The single-session jump of 23% on July 23 is the most vivid data point: that one day added more borrowed shares than the entire position carried six weeks ago. The ORTEX short score has been pinned in a narrow band between 67 and 72 for two weeks, a sign of sustained rather than episodic conviction on the short side. Availability tightened sharply this week — dropping from above 150% earlier in the week to 83.5% by July 23 — suggesting demand for new borrows is rising faster than supply is being replenished. Cost to borrow remains low at 0.76%, up 20% on the week but still well within normal territory. The borrow market is tightening but not yet stressed. Options tell a different story: the put/call ratio eased to 0.47 on Friday, its lowest reading in over a week and meaningfully below the 52-week high of 0.52 hit on July 23. Options traders appear to be rotating from hedges back toward calls, even as the short-side count grows.
The Street turned incrementally more optimistic this week. Keybanc raised its price target from $14 to $16 on July 16, maintaining an Overweight — the first upward target revision after a cluster of cuts that followed the early June earnings print. That June print triggered a wave of downgrades in targets across Morgan Stanley, TD Cowen, Piper Sandler, Oppenheimer, Mizuho, RBC, and BMO, all maintaining positive ratings while slashing targets into the $13–$19 range. The current mean target is $16.11 against a closing price of $11.53, implying roughly 40% return potential — but that gap is better read as a reflection of the Street's frustration with near-term execution than as a clean buy signal. The bull case rests on SASE market growth and cloud-AI security tailwinds. The bear case is more immediate: modest net-new ARR, a declining net retention rate, and a short score that ranks in the bottom 8th percentile of the universe. The forward earnings momentum scores — 4th percentile over 30 days, 6th over 90 days — confirm that estimate revisions have been running negative.
The stock itself has been volatile. It closed at $11.53 on July 24, up 3.2% on the day but down 15.2% on the week. The one-month gain of 21% tells you where it was before the recent slide. Peers have also struggled: CRWD fell nearly 10% on the week, RBRK dropped 7.3%, and ZS lost 5%. The cybersecurity sector has been broadly weak, which takes some of the NTSK-specific edge off the weekly decline — but the pace of short-side building stands out even in that context.
Ownership data adds a layer of tension. ICONIQ Strategic Partners bought roughly $11 million worth of shares across July 8 and July 10, adding to its 16.6% stake. The largest single-day buy — over 610,000 shares for approximately $7.2 million on July 8 — came at prices below the current level. Against that, Lightspeed Venture Partners sold around 230,000 shares across July 8 and July 9, reducing what remains a 14.8% position. CEO Sanjay Beri sold 561,474 shares on July 1 for roughly $6.1 million, though he simultaneously received an award of over 1 million shares on the same date. The net 90-day insider flow is positive at approximately $35 million, driven almost entirely by the ICONIQ accumulation, which introduces a genuine counterweight to the short-side narrative.
The earnings history adds further context. The June 3 print produced a one-day move of -17% and a five-day move of -30% — the most damaging reaction in recent record. The July 7 event showed a milder -2.5% on the day before recovering 16.8% over five sessions. The September 2 date is therefore less about whether Netskope is growing and more about whether net-new ARR and net retention can stabilise enough to stop the cycle of target cuts that has defined the stock since early June.
See the live data behind this article on ORTEX.
Open NTSK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
